Heart rate, respiratory rate and airflow variability differences between stable and exacerbating COPD patients.

Amar J Shah^1,2, Anita Saigal^1,2, Renard Pramono^3,4, Orsina Dessi⁴, John R Hurst^1,2, Ali R Mani⁵, Esther Rodriguez Villegas^3,4, Swapna Mandal^1,2

¹UCL Respiratory, University College London, London, UK.

²Royal Free London NHS Foundation Trust, London, UK.

³Wearable Technologies Lab, Department of Electrical and Electronic Engineering, Imperial College London, London, UK.

⁴Acurable Ltd, London, UK.

⁵Network Physiology Laboratory, Division of Medicine, University College London, London, UK.

PubMed PMC DOI PDF

Abstract

RATIONALE: Earlier identification and treatment of COPD exacerbations leads to improved clinical outcomes. Wearable technology has the ability to measure physiological signal variability, which is likely to be different in states of stability and exacerbation. The objectives of the present study were to analyse signals, including heart rate, respiratory rate and airflow, from a novel small wearabl…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.